| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8949924 | Pathology - Research and Practice | 2018 | 28 Pages |
Abstract
Our results do not suggest a prognostic role for CA IX overexpression in stage III NSCLC patients who received neoadjuvant treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kamuran Ibis, Sezer Saglam, Esra Kaytan Saglam, Pinar Firat, Dilek Yilmazbayhan, Alper Toker, Berker Ozkan, Veysel S. Hancer, Murat Buyukdogan, Rian Disci, Kezban Nur Pilanci,